Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2006 1
2008 1
2009 2
2010 5
2011 2
2012 3
2013 7
2014 12
2015 18
2016 25
2017 26
2018 27
2019 35
2020 21
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

164 results
Results by year
Filters applied: . Clear all
Page 1
Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance.
Saad MJ, Santos A, Prada PO. Saad MJ, et al. Physiology (Bethesda). 2016 Jul;31(4):283-93. doi: 10.1152/physiol.00041.2015. Physiology (Bethesda). 2016. PMID: 27252163 Free article. Review.
Obesity and insulin resistance are the major predisposing factors to comorbidities, such as Type 2 diabetes, nonalcoholic fatty liver disease, cardiovascular and neurodegenerative diseases, and several types of cancer. ...Here, we review
Obesity and insulin resistance are the major predisposing factors to comorbidities, such as Type 2 diabetes, nonalcohol
Nonalcoholic fatty liver disease.
Brunt EM, Wong VW, Nobili V, Day CP, Sookoian S, Maher JJ, Bugianesi E, Sirlin CB, Neuschwander-Tetri BA, Rinella ME. Brunt EM, et al. Nat Rev Dis Primers. 2015 Dec 17;1:15080. doi: 10.1038/nrdp.2015.80. Nat Rev Dis Primers. 2015. PMID: 27188459 Free article. Review.
NAFLD is closely associated with insulin resistance; obesity and metabolic syndrome are common underlying factors. As a consequence, the prevalence of NAFLD is estimated to be 10-40% in adults worldwide, and it is the most common liver disease in child …
NAFLD is closely associated with insulin resistance; obesity and metabolic syndrome are common underlying factors. As a …
Microbiota and metabolic diseases.
Pascale A, Marchesi N, Marelli C, Coppola A, Luzi L, Govoni S, Giustina A, Gazzaruso C. Pascale A, et al. Endocrine. 2018 Sep;61(3):357-371. doi: 10.1007/s12020-018-1605-5. Epub 2018 May 2. Endocrine. 2018. PMID: 29721802 Review.
There is growing evidence that any modification in the microbiota composition can lead to several diseases, including metabolic diseases, such as obesity and diabetes, and cardiovascular diseases. ...The causes of the microbiota al …
There is growing evidence that any modification in the microbiota composition can lead to several diseases, including metaboli …
Insulin resistance in obesity: an overview of fundamental alterations.
Barazzoni R, Gortan Cappellari G, Ragni M, Nisoli E. Barazzoni R, et al. Eat Weight Disord. 2018 Apr;23(2):149-157. doi: 10.1007/s40519-018-0481-6. Epub 2018 Feb 3. Eat Weight Disord. 2018. PMID: 29397563 Free article. Review.
In particular, obesity is strongly associated with the development of insulin resistance, which in turn plays a key role in the pathogenesis of obesity-associated cardiometabolic complications, including metabolic syndrome components, type 2 diabetes, …
In particular, obesity is strongly associated with the development of insulin resistance, which in turn plays a key rol …
GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
Barengolts E. Barengolts E. Endocr Pract. 2016 Oct;22(10):1224-1234. doi: 10.4158/EP151157.RA. Epub 2016 Jul 13. Endocr Pract. 2016. PMID: 27409822 Review.
METHODS: Primary literature was reviewed on the topics including RCTs of pre-, pro- and synbiotics use for metabolic disease. RESULTS: Gut bacteria (microbiota) benefit digestion and have multiple other functions. ...CONCLUSION: Pre-, pro-, and synbiotics cou …
METHODS: Primary literature was reviewed on the topics including RCTs of pre-, pro- and synbiotics use for metabolic disease. RESULTS …
Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome.
Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y, Wang L, Zhang Y, Liang X, Wang L, Gonzalez FJ, Patterson AD, Liu H, Mu L, Zhou Z, Zhao Y, Li R, Liu P, Zhong C, Pang Y, Jiang C, Qiao J. Qi X, et al. Nat Med. 2019 Aug;25(8):1225-1233. doi: 10.1038/s41591-019-0509-0. Epub 2019 Jul 22. Nat Med. 2019. PMID: 31332392 Free PMC article.
Polycystic ovary syndrome (PCOS) is characterized by androgen excess, ovulatory dysfunction and polycystic ovaries(1), and is often accompanied by insulin resistance(2). The mechanism of ovulatory dysfunction and insulin resistance in PCOS remains elus …
Polycystic ovary syndrome (PCOS) is characterized by androgen excess, ovulatory dysfunction and polycystic ovaries(1), and is often accompan …
Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome.
de Toro-Martín J, Arsenault BJ, Després JP, Vohl MC. de Toro-Martín J, et al. Nutrients. 2017 Aug 22;9(8):913. doi: 10.3390/nu9080913. Nutrients. 2017. PMID: 28829397 Free PMC article. Review.
In a world characterized by an overwhelming increase in the prevalence of obesity and associated metabolic disturbances, such as type 2 diabetes and cardiovascular diseases, tailored nutrition prescription represents a promising approach for both the preventi …
In a world characterized by an overwhelming increase in the prevalence of obesity and associated metabolic disturbances, such as type …
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.
Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, Chilloux J, Ottman N, Duparc T, Lichtenstein L, Myridakis A, Delzenne NM, Klievink J, Bhattacharjee A, van der Ark KC, Aalvink S, Martinez LO, Dumas ME, Maiter D, Loumaye A, Hermans MP, Thissen JP, Belzer C, de Vos WM, Cani PD. Plovier H, et al. Nat Med. 2017 Jan;23(1):107-113. doi: 10.1038/nm.4236. Epub 2016 Nov 28. Nat Med. 2017. PMID: 27892954 Free article. Clinical Trial.
Obesity and type 2 diabetes are associated with low-grade inflammation and specific changes in gut microbiota composition. ...Unexpectedly, we discovered that pasteurization of A. muciniphila enhanced its capacity to reduce fat mass development, insulin
Obesity and type 2 diabetes are associated with low-grade inflammation and specific changes in gut microbiota compositi
Plant-Based Diets in the Reduction of Body Fat: Physiological Effects and Biochemical Insights.
Najjar RS, Feresin RG. Najjar RS, et al. Nutrients. 2019 Nov 8;11(11):2712. doi: 10.3390/nu11112712. Nutrients. 2019. PMID: 31717463 Free PMC article. Review.
Obesity affects over one-third of Americans and increases the risk of cardiovascular disease and type II diabetes. ...This review discusses six major dietary mechanisms that may lead to reduced body fat. These include (1) reduced caloric density, (2) improved
Obesity affects over one-third of Americans and increases the risk of cardiovascular disease and type II diabetes. ...T
Functional interactions between the gut microbiota and host metabolism.
Tremaroli V, Bäckhed F. Tremaroli V, et al. Nature. 2012 Sep 13;489(7415):242-9. doi: 10.1038/nature11552. Nature. 2012. PMID: 22972297 Review.
The link between the microbes in the human gut and the development of obesity, cardiovascular disease and metabolic syndromes, such as type 2 diabetes, is becoming clearer. ...Through increased knowledge of the mechanisms involved in the interactions b …
The link between the microbes in the human gut and the development of obesity, cardiovascular disease and metabo …
164 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page